MMI announces global imaging services collaboration with Micron
Medical Metrics, Inc. is proud to have worked with Optinose on their ReOpen clinical trials, which have recently received FDA approval! A heartfelt thank you to all our amazing collaborators, including our dedicated neuroradiologist readers, Key Opinion Leader consultants, and the incredible project personnel on both teams!
In a research letter in Spine, MMI collaborated with researchers to investigate the SPSI as an objective measure of instability in lumbar stenosis patients with degenerative spondylolisthesis.
MMI co-founder, Dr. John Hipp, was recognized for his outstanding contributions to spine basic research.
A recent study took advantage of Medical Metrics state-of-the-art Quantitative Motion Analysis, or QMA®, software to track the motion of cervical disk replacements with extreme precision.
Medical Metrics, Inc. (MMI), a leading provider of imaging core lab services for orthopedic clinical trials, has been selected by five leading orthopedic device manufacturers to support multiple cross-sectional, post-market, FDA surveillance studies of metal-on-metal (MoM) hip implants. MMI will independently evaluate radiographs and MRI to assess long-term outcomes in patients implanted with MoM hips. …
MMI’s scientific staff and physician consultants specialize in joint replacement studies and the current client list includes global leaders in joint arthroplasty.
Medical Metrics, Inc. (MMI), an experienced provider of medical imaging core lab services for global clinical trials, has been selected by Exactech, Inc. to conduct an independent evaluation of medical images from the BiPhasic Cartilage Repair Implant (BiCRI) IDE Clinical Trial approved by the Taiwan FDA. This prospective, randomized study will be conducted in Taiwan to …
Medical Metrics, Inc. (MMI) announces that it has successfully achieved ISO 9001:2008 certification of its Quality Management System in support of imaging core lab services for orthopedic, spine, cardiovascular and neurological clinical trials.
QMA® continues to gain widespread acceptance in pre-clinical, clinical and research applications studying intervertebral motion as evidenced by the growing number of scientific publications.
